{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T04:40:51Z","timestamp":1773204051496,"version":"3.50.1"},"reference-count":27,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["psy-journal.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Psychiatry Research"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/j.psychres.2016.03.015","type":"journal-article","created":{"date-parts":[[2016,3,8]],"date-time":"2016-03-08T12:33:13Z","timestamp":1457440393000},"page":"184-189","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study"],"prefix":"10.1016","volume":"239","author":[{"given":"Young-Min","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Hwan","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bun-Hee","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kyu Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kye-Seong","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung-Gul","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hwa-Young","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib1","first-page":"29","article-title":"Hyperprolactinemia associated with risperidone: a case report and review of literature","volume":"1","author":"Aboraya","year":"2004","journal-title":"Psychiatry"},{"issue":"5","key":"10.1016\/j.psychres.2016.03.015_bib2","doi-asserted-by":"crossref","first-page":"341","DOI":"10.3109\/08039488.2013.839739","article-title":"Increased serum prolactin levels in drug-naive first-episode male patients with schizophrenia","volume":"68","author":"Albayrak","year":"2014","journal-title":"Nord. J. Psychiatry"},{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib3","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1002\/hup.924","article-title":"Sexual dysfunction in schizophrenia: focus on recent evidence","volume":"23","author":"Baggaley","year":"2008","journal-title":"Hum. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2016.03.015_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1191\/096120301717165001","article-title":"Analysis of anti-prolactin autoantibodies in systemic lupus erythematosus","volume":"10","author":"Blanco-Favela","year":"2001","journal-title":"Lupus"},{"issue":"4","key":"10.1016\/j.psychres.2016.03.015_bib5","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S1043-6618(03)00174-9","article-title":"Risperidone-associated hyperprolactinemia: evaluation in twenty psychiatric outpatients","volume":"48","author":"Brunelleschi","year":"2003","journal-title":"Pharm. Res."},{"issue":"5","key":"10.1016\/j.psychres.2016.03.015_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1517\/14740338.2014.906579","article-title":"Second-generation and newly approved antipsychotics, serum prolactin levels and sexual dysfunctions: a critical literature review","volume":"13","author":"De Hert","year":"2014","journal-title":"Expert Opin. Drug Saf."},{"issue":"5","key":"10.1016\/j.psychres.2016.03.015_bib7","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1016\/j.beem.2013.07.002","article-title":"Determination of prolactin: the macroprolactin problem","volume":"27","author":"Fahie-Wilson","year":"2013","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"issue":"2 Suppl.","key":"10.1016\/j.psychres.2016.03.015_bib8","doi-asserted-by":"crossref","first-page":"S12","DOI":"10.1177\/0269216307087148","article-title":"Prolactin and dopamine: what is the connection? A review article","volume":"22","author":"Fitzgerald","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"20","key":"10.1016\/j.psychres.2016.03.015_bib9","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.2165\/00003495-200464200-00003","article-title":"Antipsychotic-induced hyperprolactinaemia: mechanisms, clinical features and management","volume":"64","author":"Haddad","year":"2004","journal-title":"Drugs"},{"issue":"10","key":"10.1016\/j.psychres.2016.03.015_bib10","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3109\/00048674.2011.589044","article-title":"Antipsychotic-induced hyperprolactinaemia","volume":"45","author":"Inder","year":"2011","journal-title":"Aust. N. Z. J. Psychiatry"},{"issue":"6","key":"10.1016\/j.psychres.2016.03.015_bib11","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1097\/JCP.0b013e31818ba5d8","article-title":"Antipsychotic-induced hyperprolactinemia: a cross-sectional survey","volume":"28","author":"Johnsen","year":"2008","journal-title":"J. Clin. Psychopharmacol."},{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib12","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1124\/jpet.102.035303","article-title":"The differential effects of atypical antipsychotics on prolactin elevation are explained by their differential blood\u2013brain disposition: a pharmacological analysis in rats","volume":"302","author":"Kapur","year":"2002","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"Suppl. 2","key":"10.1016\/j.psychres.2016.03.015_bib13","doi-asserted-by":"crossref","first-page":"S69","DOI":"10.1016\/S0306-4530(02)00128-2","article-title":"Hyperprolactinemia in response to antipsychotic drugs: characterization across comparative clinical trials","volume":"28","author":"Kinon","year":"2003","journal-title":"Psychoneuroendocrinology"},{"issue":"2 Suppl.","key":"10.1016\/j.psychres.2016.03.015_bib14","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1177\/0269216307087147","article-title":"The evolution of hyperprolactinaemia as an entity in psychiatric patients","volume":"22","author":"Kohen","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"Suppl. 1","key":"10.1016\/j.psychres.2016.03.015_bib15","doi-asserted-by":"crossref","first-page":"S621","DOI":"10.1111\/j.1439-0272.2011.01240.x","article-title":"Drug-inducing gynaecomastia \u2013 a critical review","volume":"44","author":"Krause","year":"2012","journal-title":"Andrologia"},{"issue":"1","key":"10.1016\/j.psychres.2016.03.015_bib16","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/j.1440-1819.2011.02296.x","article-title":"Hyperprolactinemia induced by low-dosage amisulpride in Korean psychiatric patients","volume":"66","author":"Lee","year":"2012","journal-title":"Psychiatry Clin. Neurosci."},{"issue":"6","key":"10.1016\/j.psychres.2016.03.015_bib17","doi-asserted-by":"crossref","first-page":"2743","DOI":"10.1210\/jcem.86.6.7521","article-title":"Laboratory and clinical experience in 55 patients with macroprolactinemia identified by a simple polyethylene glycol precipitation method","volume":"86","author":"Leslie","year":"2001","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib18","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/archpsyc.1976.01770030003001","article-title":"The effect of neuroleptics on serum prolactin in schizophrenic patients","volume":"33","author":"Meltzer","year":"1976","journal-title":"Arch. Gen. Psychiatry"},{"issue":"2 Suppl.","key":"10.1016\/j.psychres.2016.03.015_bib19","doi-asserted-by":"crossref","first-page":"S98","DOI":"10.1177\/0269881107087346","article-title":"Antipsychotics and hyperprolactinaemia: clinical recommendations","volume":"22","author":"Peveler","year":"2008","journal-title":"J. Psychopharmacol."},{"issue":"10","key":"10.1016\/j.psychres.2016.03.015_bib20","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1093\/rheumatology\/keh307","article-title":"Raised serum prolactin in rheumatoid arthritis: genuine or laboratory artefact?","volume":"43","author":"Ram","year":"2004","journal-title":"Rheumatology"},{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib21","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1097\/MJT.0b013e3182456de7","article-title":"Hyperprolactinemia with aripiprazole: understanding the paradox","volume":"21","author":"Saraf","year":"2014","journal-title":"Am. J. Ther."},{"issue":"6","key":"10.1016\/j.psychres.2016.03.015_bib22","first-page":"575","article-title":"Diagnosis and management of hyperprolactinemia","volume":"169","author":"Serri","year":"2003","journal-title":"CMAJ"},{"key":"10.1016\/j.psychres.2016.03.015_bib23","doi-asserted-by":"crossref","first-page":"167132","DOI":"10.1155\/2012\/167132","article-title":"Macroprolactinemia: diagnostic, clinical, and pathogenic significance","volume":"2012","author":"Shimatsu","year":"2012","journal-title":"Clin. Dev. Immunol."},{"issue":"3","key":"10.1016\/j.psychres.2016.03.015_bib24","doi-asserted-by":"crossref","first-page":"261","DOI":"10.3109\/10398561003686763","article-title":"Hyperprolactinaemia during treatment with paliperidone","volume":"18","author":"Skopek","year":"2010","journal-title":"Aust. Psychiatry"},{"key":"10.1016\/j.psychres.2016.03.015_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.2147\/NDT.S34433","article-title":"Profile of blonanserin for the treatment of schizophrenia","volume":"9","author":"Tenjin","year":"2013","journal-title":"Neuropsychiatr. Dis. Treat."},{"issue":"2","key":"10.1016\/j.psychres.2016.03.015_bib26","doi-asserted-by":"crossref","first-page":"293","DOI":"10.4088\/JCP.08l04509","article-title":"Is second-generation antipsychotic-induced hyperprolactinemia due to biologically active prolactin or to biologically inactive macroprolactin? Results from a prospective study","volume":"70","author":"Tschoner","year":"2009","journal-title":"J. Clin. Psychiatry"},{"issue":"8","key":"10.1016\/j.psychres.2016.03.015_bib27","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1517\/17425255.2013.791283","article-title":"Drug-induced hypo- and hyperprolactinemia: mechanisms, clinical and therapeutic consequences","volume":"9","author":"Voicu","year":"2013","journal-title":"Expert Opin. Drug Metab. Toxicol."}],"container-title":["Psychiatry Research"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116303997?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0165178116303997?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T09:56:14Z","timestamp":1536918974000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0165178116303997"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,5]]},"references-count":27,"alternative-id":["S0165178116303997"],"URL":"https:\/\/doi.org\/10.1016\/j.psychres.2016.03.015","relation":{},"ISSN":["0165-1781"],"issn-type":[{"value":"0165-1781","type":"print"}],"subject":[],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prolactin and macroprolactin levels in psychiatric patients receiving atypical antipsychotics: A preliminary study","name":"articletitle","label":"Article Title"},{"value":"Psychiatry Research","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.psychres.2016.03.015","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}